Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report
Xia Yang1, Wei Liu1,2, Allie Lyons1,3
1Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China.
Background:
The incidence of cytarabine-induced pericarditis is rare. So far, only a few cases have been reported worldwide.
Description Of The Case:
We are reporting a case of a 25-year-old male with acute myeloid leukemia (AML M2a) on chemotherapy who developed acute pericarditis after the administration of a cytarabine-containing regimen. The symptoms gradually improved after symptomatic treatment with steroids and other drugs.
Conclusions:
This case demonstrates that, although pericarditis induced by cytarabine is rare, early recognition of this potentially life-threatening complication and appropriate management will usually result in the patient's recovery.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Pericarditis IV: Nursing Management
Myocarditis III: Medical Management
Myocarditis I: Introduction
